Koshinski Asset Management, Inc. Jounce Therapeutics, Inc. Transaction History

Koshinski Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 12, 2022	SELL	$2.8 - $7.67 $840 - $2,301	-300 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$5.04 - $8.73 $1,512 - $2,619	300 New	300 $2,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.